Chinia Vaccine Sinopharm and Sinovac

Are Chinese Covid jabs effective?

eAwaz Medicine

Beijing – Some studies have shown that the effectiveness of some of the Chinese CoronaVac and Sinopharm Covid vaccines may be waning in immunity levels. CoronaVac and Sinopharm account for almost 50 per cent of the 7.3 billion Covid-19 vaccine doses delivered globally. But Gagandeep Kang, a virologist at the Christian Medical College in India’s Vellore, who advises SAGE, has said: …

Moderna to Build State-of-the-Art Facility in Africa to Manufacture up to 500 Million Doses Per Year

eAwaz Medicine

CAMBRIDGE – Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced it will build a state-of-the-art mRNA facility in Africa with the goal of producing up to 500 million doses of vaccines each year at the 50 µg dose level. The Company anticipates investing up to $500 million in this new facility which is expected to include drug …

Resurfacing treatment for post-menopause

eAwaz Medicine

TORONTO – A special type of laser resurfacing treatment popularly used for skin-related corrections is being marketed as an alternative treatment for a condition that affects women after menopause. Fractional carbon dioxide laser is a minimally-invasive procedure and improves look of skin damage. FDA has warned against it but Health Canada has approved several such devices for that specific use …

Janssen Announces Novel Mechanism of Action that Shows Promise Against Dengue

eAwaz Medicine

BELGIUM – The Janssen Pharmaceutical Companies of Johnson & Johnson (Janssen) announced, in collaboration with the KU Leuven Rega Institute and the KU Leuven Centre for Drug Design and Discovery (CD3), the publication of new preclinical data in the journal Nature showing that an early-stage compound with a novel mechanism of action could potentially treat all serotypes of dengue fever …

Merck asks FDA to authorize anti-COVID-19 pill

eAwaz Medicine

WASHINGTON (AP) – Drugmaker Merck asked US regulators Monday to authorize its pill for treating COVID-19 in what would add an entirely new and easy-to-use weapon to the world’s arsenal against the pandemic. If cleared by the Food and Drug Administration — a decision that could come in a matter of weeks — it would be the first pill shown to …

J & J single-shot vaccine has 75% efficacy but boosters required

eAwaz Medicine

NEW BRUNSWICK -The largest real-world evidence study for a COVID-19 vaccine reported to date in the U.S. demonstrated stable vaccine effectiveness of 79 percent (CI, 77%-80%) for COVID-19-related infections and 81 percent (CI, 79%-84%) for COVID-19-related hospitalizations. There was no evidence of reduced effectiveness over the study duration, including when the Delta variant became dominant in the U.S. Sequencing data were not …

Pfizer seeks Canadian approval for its vaccine for five-year-olds

eAwaz Medicine

OTTAWA – Pfizer Canada says it is preparing to ask Health Canada to authorize its COVID-19 vaccine for kids as young as five by mid-October. The U.S. drugmaker submitted a formal request to the U.S. Food and Drug Administration today and the FDA intends to meet to discuss the submission on Oct. 26. Last week Pfizer submitted data to both …

J&J seeking FDA clearance on COVID-19 vaccine booster

eAwaz Medicine

London (AP) – Johnson & Johnson asked the Food and Drug Administration on Tuesday to allow extra shots of its COVID-19 vaccine as the U.S. government moves toward expanding its booster campaign to millions more vaccinated Americans. J&J said it filed a request with the FDA to authorize boosters for people who previously received the company’s one-shot vaccine. While company said it submitted data on several different booster intervals, ranging …

EU regulator OKs Pfizer vaccine booster for 18 and older

eAwaz Medicine

AMSTERDAM — The European Union’s drug regulator gave its backing Monday to booster shots of the Pfizer-BioNTech COVID-19 vaccine for people 18 and older. The European Medicines Agency said the booster doses “may be considered at least 6 months after the second dose for people aged 18 years and older.” The agency’s human medicines committee issued the recommendation after studying …

Injectable electrically conductive patch could help restore cardiac function after heart failure, study

eAwaz Medicine

TORONTO – A minimally invasive cardiac patch made out of carbon nanotubes could be a promising solution for patients with heart failure, a new Canadian-led study suggests. A group of scientists has developed an electrically conductive patch that can be rolled into a syringe or commercial catheter and injected into the damaged heart area, according to a peer-reviewed study published recently in …